Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQun Zhao
About this trial
This study aims to develop and validate an artificial intelligence (AI) model that integrates clinical, pathological, and imaging data to predict the presence of lymph node metastasis (LNM) in patients with T1-stage gastric cancer.
The study will also compare the diagnostic performance of physicians with and without AI assistance, including clinicians with varying levels of experience.
The goal is to improve early decision-making and support more personalized treatment strategies for patients with early gastric cancer.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Multimodal Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in T1 Gastric Cancer
Treatment groups
No treatment groups listed
Sponsors and collaborators
Qun Zhao
Lead sponsor
Hebei Medical University
Sponsor institution
Source ClinicalTrials.gov